Markus Graefen Selected Research

Extranodal Extension

11/2017	Impact of preoperative risk on metastatic progression and cancer-specific mortality in patients with adverse pathology at radical prostatectomy.
10/2014	Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasis.
1/2011	Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.
2/2009	Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
12/2007	Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
12/2007	Prostate volume and adverse prostate cancer features: fact not artifact.
6/2007	Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
12/2006	Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.
3/2006	Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
12/2005	Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Graefen Research Topics

Disease

380	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 02/2002
197	Neoplasms (Cancer) 09/2022 - 02/2002
46	Margins of Excision 01/2022 - 04/2003
37	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2006
24	Carcinoma (Carcinomatosis) 06/2022 - 08/2002
23	Lymphatic Metastasis 01/2021 - 11/2003
15	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 10/2009
11	Extranodal Extension 11/2017 - 02/2004
10	Urinary Bladder Neoplasms (Bladder Cancer) 09/2022 - 07/2009
7	Urinary Incontinence 11/2021 - 05/2011
5	Obesity 06/2022 - 08/2007
5	Erectile Dysfunction 01/2021 - 04/2007
5	7 Hereditary Prostate Cancer 07/2020 - 06/2011
4	Genomic Instability 01/2021 - 01/2020
3	Delirium 08/2022 - 03/2020
3	Kidney Neoplasms (Kidney Cancer) 06/2022 - 09/2012
3	Lymphocele 12/2021 - 02/2003
3	Disease Progression 07/2015 - 01/2009
3	Carcinogenesis 01/2015 - 09/2013
2	Infections 01/2021 - 11/2019
2	Emergence Delirium 06/2020 - 03/2020
2	Rectal Neoplasms (Rectal Cancer) 12/2019 - 02/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2014 - 09/2014
2	Inguinal Hernia (Direct Inguinal Hernia) 12/2010 - 03/2010
2	Prostatic Intraepithelial Neoplasia 11/2010 - 03/2010
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2006 - 12/2003
2	Prostatic Diseases 04/2005 - 11/2002
1	Melanoma (Melanoma, Malignant) 01/2022
1	Ductal Carcinoma 01/2022
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

98	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 03/2002
23	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2005
22	AndrogensIBA 01/2022 - 11/2003
20	AntigensIBA 06/2022 - 11/2010
20	Biomarkers (Surrogate Marker)IBA 10/2020 - 09/2005
11	Hormones (Hormone)IBA 01/2022 - 02/2004
10	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 08/2012
8	TensinsIBA 01/2020 - 08/2012
7	Pharmaceutical PreparationsIBA 12/2020 - 08/2010
6	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 09/2006
6	Dihydrotachysterol (AT 10)IBA 10/2021 - 05/2012
6	Biological ProductsIBA 02/2020 - 04/2005
6	Androgen Receptors (Androgen Receptor)IBA 12/2019 - 03/2013
5	Serine Proteases (Serine Protease)IBA 01/2020 - 01/2013
4	gallium 68 PSMA-11IBA 12/2021 - 03/2016
4	Protein Isoforms (Isoforms)IBA 07/2015 - 06/2004
4	Tissue Kallikreins (Tissue Kallikrein)IBA 04/2005 - 02/2003
3	Indicators and Reagents (Reagents)IBA 12/2020 - 07/2015
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2013
3	Capsules (Microcapsules)IBA 11/2016 - 06/2006
3	isopropyl cyanoacrylateIBA 01/2015 - 08/2008
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2014 - 08/2010
2	enzalutamideIBA 01/2022 - 12/2020
2	Kallikreins (Kallikrein)IBA 01/2021 - 01/2020
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 07/2015
2	AlkaloidsIBA 12/2020 - 01/2020
2	SurvivinIBA 01/2020 - 01/2020
2	LigandsIBA 01/2020 - 03/2016
2	6-bromo-2-naphthyl sulfate (BNS)IBA 01/2020 - 11/2012
2	Phosphotransferases (Kinase)IBA 01/2019 - 06/2008
2	Messenger RNA (mRNA)IBA 09/2017 - 02/2008
2	Testosterone (Sustanon)FDA Link 01/2017 - 08/2010
2	Histones (Histone)IBA 11/2015 - 06/2015
2	Phosphodiesterase 5 InhibitorsIBA 02/2015 - 10/2008
2	Phenobarbital (Luminal)FDA Link 01/2015 - 01/2015
2	Fluconazole (Zonal)FDA LinkGeneric 04/2007 - 07/2003
1	Dronabinol (THC)FDA LinkGeneric 09/2022
1	3-methoxybutylcyanoacrylateIBA 07/2022
1	HalogensIBA 03/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2022
1	pembrolizumabIBA 01/2022
1	apalutamideIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	abirateroneIBA 01/2022
1	darolutamideIBA 01/2022
1	68Ga-DOTAGA-(3-iodo-y)fk(Sub-KuE)IBA 12/2021

Therapy/Procedure

282	Prostatectomy (Retropubic Prostatectomy) 10/2022 - 02/2002
62	Therapeutics 03/2022 - 11/2003
60	Radiotherapy 10/2022 - 11/2003
41	Lymph Node Excision (Lymph Node Dissection) 06/2022 - 02/2002
19	Nephrectomy 06/2022 - 10/2009
13	Cystectomy 09/2022 - 07/2009
8	Brachytherapy 11/2021 - 07/2007
7	Drug Therapy (Chemotherapy) 06/2022 - 01/2010
7	Castration 01/2022 - 01/2018
7	Nephroureterectomy 04/2012 - 11/2009
5	Length of Stay 02/2022 - 09/2012
5	Adjuvant Radiotherapy 01/2022 - 03/2008
4	Catheters 11/2021 - 07/2014
3	Combined Modality Therapy 01/2020 - 02/2015
3	Salvage Therapy 12/2017 - 11/2003
3	Blood Transfusion (Blood Transfusions) 07/2014 - 04/2012
2	Neoadjuvant Therapy 02/2022 - 01/2022
2	Orchiectomy (Orchidectomy) 12/2014 - 12/2014
2	Transurethral Resection of Prostate (TURP) 05/2014 - 08/2009
2	Treatment Delay 08/2013 - 06/2005
1	Thrombectomy 06/2022
1	Immunotherapy 02/2022
1	Aftercare (After-Treatment) 01/2022